4//SEC Filing
Landis John B. 4
Accession 0001562180-23-001335
CIK 0001314102other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:05 PM ET
Size
7.0 KB
Accession
0001562180-23-001335
Insider Transaction Report
Form 4
Landis John B.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-02-09+3,000→ 11,400 total - Exercise/Conversion
Restricted Stock Units
2023-02-09−3,000→ 0 totalExercise: $0.00→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]Fully vested on the one-year anniversary of the grant date.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001477283
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:05 PM ET
- Size
- 7.0 KB